M. Lebwohl, A. Blauvelt, A. Menter, K. Papp, and A. Jacobson, “Long-term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab”, J of Skin, vol. 3, p. S26, Nov. 2019.